Health coach-supported mobile health intervention to improve adherence to lipid-lowering medications (AdLip): Design and rationale of a multicentre randomized controlled trial protocol
PLOS One · 05.05.2026 · 21 (5) · e0346509
DOI: 10.1371/journal.pone.0346509 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 05.05.2026. Verfasst von Qi Chwen Ong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperlipidemias, Hypolipidemic Agents, Medication Adherence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CArdiovascular DiseasE National Collaborative Enterprise, National Medical Research Council, Ministry of Health -Singapore.
Abstract (Originalsprache)
Background
Elevated low-density lipoprotein cholesterol is one of the major modifiable risk factors for cardiovascular disease. Lipid management is integral to primary and secondary prevention of cardiovascular disease, but undermined by high prevalence of non-adherence to lipid-lowering medications. Innovative, personalized multicomponent interventions may address the gaps in medication non-adherence. We aim to evaluate the effectiveness of a human coach-supported digital personal health assistant (mobile health app) intervention in improving adherence to statins in adults with hyperlipidaemia.
Methods
AdLip is a multicentre, open-label, parallel, two-arms, randomized controlled trial aiming to recruit a minimum of 376 adult participants who are non-adherent to statins from primary care ambulatory clinic setting in Singapore. Participants recruited will be randomly assigned (1:1) to human-coach supported mobile health app intervention or control group. The primary outcome will be adherence to statins at 6 months, measured by Medication Adherence Report Scale-5. Secondary outcomes will include change in serum low-density lipoprotein cholesterol levels, health motivation and attitudes, self-efficacy, self-care behaviours, quality of life, app acceptability, user engagement, and cost-effectiveness. Outcomes will be analysed using intention-to-treat approach.
Discussion
The AdLip trial will provide empirical evidence on a multicomponent approach to the long-standing challenge of suboptimal adherence to statins in a multi-ethnic Asian setting. Findings from this study may inform a more personalized approach to addressing non-adherence in the short term, and how it relates to cardiovascular disease prevention in the longer term. Trial Registration: ClinicalTrials.gov NCT06614049 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- Cardiovascular Disease National Collaborative Enterprise, Consortium for Clinical Research and Innovation, Singapore, Singapore.
- Health Services & Systems Research, Duke-National University of Singapore Medical School, Singapore, Singapore.
- National Heart Research Institute Singapore, National Heart Centre, Singapore, Singapore.
- Cardiovascular Research Institute, National University Health System, Singapore, Singapore.
- Centre for Behavioural & Implementation Science Interventions, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore.
ORCID-Profile: Qi Chwen Ong, Emina Obarcanin, Sameera Senanayake, Andy Hau Yan Ho
Förderung
- CArdiovascular DiseasE National Collaborative Enterprise
- National Medical Research Council
- Ministry of Health -Singapore
Zitieren
APA
Ong, Q. C., Obarcanin, E., Bojic, I., Tan, S. H., Senanayake, S., Kularatna, S., Graves, N., Chan, S. P., Sim, J. L. M., Hausenloy, D., Chan, M. Y. Y., Khong, A. W. H., Tan, D. S., & Ho, A. H. Y. (2026). Health coach-supported mobile health intervention to improve adherence to lipid-lowering medications (AdLip): Design and rationale of a multicentre randomized controlled trial protocol. PLOS One, 21(5), e0346509. https://doi.org/10.1371/journal.pone.0346509
Vancouver
Ong QC, Obarcanin E, Bojic I, Tan SH, Senanayake S, Kularatna S, et al. Health coach-supported mobile health intervention to improve adherence to lipid-lowering medications (AdLip): Design and rationale of a multicentre randomized controlled trial protocol. PLOS One. 2026;21(5):e0346509. doi:10.1371/journal.pone.0346509
BibTeX
@article{Ong2026,
author = {Ong, Qi Chwen and Obarcanin, Emina and Bojic, Iva and Tan, Sock Hwee and Senanayake, Sameera and Kularatna, Sanjeewa and Graves, Nicholas and Chan, Siew Pang and Sim, Jun Long Marvin and Hausenloy, Derek and Chan, Mark Yan Yee and Khong, Andy Wai Hoong and Tan, Doreen Su-Yin and Ho, Andy Hau Yan},
title = {Health coach-supported mobile health intervention to improve adherence to lipid-lowering medications (AdLip): Design and rationale of a multicentre randomized controlled trial protocol},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0346509},
doi = {10.1371/journal.pone.0346509}
}
EUVIMED